Healthcare Products: Drugs, Devices & Lab Tools

Own manufacturers supplying patient treatment and medical research rather than healthcare insurers, care platforms or a single therapeutic pipeline. Combining medicines, medical devices and laboratory products creates a distinct healthcare-products basket with different demand drivers. Danaher's recent quarterly results provide a timely checkpoint for research and diagnostics demand as doubts about AI spending encourage diversification; reimbursement pressure and research-budget weakness remain risks. Catalysts: - 2026-10-21 DHR: Danaher Reports Third Quarter 2026 Results (https://investors.danaher.com/2026-10-21-Danaher-Reports-Third-Quarter-2026-Results) Launch basket (equal weight): JNJ, MDT, TMO, ABBV, AMGN, DHR, ABT, SYK Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.